MSD
ROTATEQ
₹ 897.2 / Piece
No Charges till Medical Approval
RotaTeq Drops – Protection Against Rotavirus
Overview:
RotaTeq is an oral vaccine designed to protect infants from severe gastroenteritis caused by rotavirus, a leading cause of diarrhea and dehydration in young children.
Key Benefits:
- Broad Protection: Shields against five rotavirus strains
- Easy Administration: Given as oral drops, making it stress-free for parents and infants
- Clinically Proven: Extensively tested and approved for safety and efficacy
Dosage & Schedule:
- Three-dose series
- First dose: At 6 weeks of age
- Subsequent doses: At 4-week intervals
- Final dose: Before 32 weeks of age
Contraindications:
- Severe allergic reactions to any component of the vaccine
- Severe Combined Immunodeficiency (SCID)
- History of intussusception
Common Side Effects:
- Mild diarrhea, vomiting, and fussiness
- Ensure hydration and monitor for any unusual symptoms
RotaTeq is a safe and effective way to prevent severe rotavirus infections, reducing hospitalizations and complications in infants.
Prescription Compulsory
Painless (gentle) | Yes |
< 6 month age | Yes |
Imported | Yes, USA |
Doses | 3 |
Antigens | 5 |
Vaccine Type | oral drops |
ACVIP 2020 Guidelines | Yes |
6wk- 8 months | Yes |
RotaTeq Drops Protect Your Child from Rotavirus
Description:
Protect your child from severe gastroenteritis with RotaTeq, an oral vaccine designed to provide immunity against rotavirus. Rotavirus is a leading cause of severe diarrhea and vomiting in infants and young children, leading to dehydration and hospitalizations. RotaTeq drops offer a safe and effective way to prevent these complications.
Key Benefits:
- Comprehensive Protection: Shields against multiple(5) strains of rotavirus.
- Oral Administration: Easy to administer drops make vaccination stress free for both parents and children.
- Clinically Proven: Extensive research and approvals from global health authorities ensure safety and efficacy.
Ideal for:
- Age Group: Suitable for infants starting at 6 weeks of age.
- Routine Immunization: Recommended as part of the standard immunization schedule to protect against severe rotavirus infections.
Schedule and Dosage:
- Dosage: Administered in three doses. Can be given with or without feeds.
- Timing: First dose at 6 weeks of age, followed by subsequent 2 doses at 4 week intervals. The final dose should be given by 32 weeks of age.
Safety in Pregnancy and Lactation:
- Pregnancy: Not applicable.RotaTeq is not intended for use in pregnant women as it is a pediatric vaccine.
- Lactation: Not applicable.RotaTeq drops are safe for breastfeeding mothers and their infants. Breastfeeding does not interfere with the effectiveness of the vaccine.
Contraindications:
- Severe Allergic Reactions: Contraindicated in individuals who have had a severe allergic reaction (e.g., anaphylaxis) to any component of the vaccine or following a previous dose of RotaTeq.
- Severe Combined Immunodeficiency (SCID): Contraindicated in infants diagnosed with SCID.
- History of Intussusception: Infants with a history of intussusception should not receive RotaTeq.
What to Expect:
- Common Side Effects: Generally mild, including fussiness, mild diarrhea, and vomiting.
- PostVaccination Care: Ensure your child stays hydrated and comfortable. Monitor for any unusual symptoms and consult your healthcare provider if you have concerns.
Reviews and Ratings
No Customer Reviews
Share your thoughts with other customers